kvorak wrote: Finally... somebody agrees. The reason people can't answer this question objectively is because it's the WRONG QUESTION, lol. Well said.
Feb. 5, 2010 03:47 PM EST
| By Rudy Sims | Article Rating: |
|
| June 26, 2009 12:15 AM EDT | Reads: |
809 |
I was very sad to hear about Michael Jackson's death I grew up with his music I'm currently 31 years old and despite my disability I did my best as a young child to imitate his dance moves when I was dancing to his music whether it was in my wheelchair or on my knees his music helped me forget about my disability for that time.
Here is a round up of several new stories about Michael Jackson's health and sudden death
Michael Jackson Dies of Reported Cardiac Arrest - webmd.com
Michael Jackson had history of health problems - CNN
Michael Jackson's Mysterious Medical Past TIME
Doctors attempt to resuscitate Michael Jackson for over an hour - NME.com
michael jackson health history Google Search
michael jackson health history Google Search
- Chase and Facebook Announce 100 Small and Local Charities to Receive $25,000 Each from Chase Community Giving
- UK Stem Cell Foundation & MS Society Stem Cell Research Collaboration
- Medical Billing Software Provider Promotes Philanthropic Contributions Company-Wide
- Defense Department to Support Fragile X Research
- DOMAINfest Global 2010 Offers Compelling Agenda and Expert Speakers
- Two-Year Results From CLARITY Study With Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
- Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients
- Stem Cell Therapeutics Corp. Receives 'No Objection Letter' From Health Canada for the Phase IIa Clinical Trial in Traumatic Brain Injury Patients
- Bazaarvoice Plans for Record-Breaking Year as It Brings Social Commerce to Brands Around the Globe
- Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004
- Natural Chelation Alternative Offers New, Non-Invasive Approach to Autism Spectrum Disorder Treatment
- CBS Films Announces 'Extraordinary Measures' Inspirational Quilt
- Contrary Opinion: CRM is a Hoax
- Chase and Facebook Announce 100 Small and Local Charities to Receive $25,000 Each from Chase Community Giving
- UK Stem Cell Foundation & MS Society Stem Cell Research Collaboration
- Merck Serono Receives Refuse to File Letter From FDA on Cladribine Tablets New Drug Application
- Medical Billing Software Provider Promotes Philanthropic Contributions Company-Wide
- Defense Department to Support Fragile X Research
- PSEG Celebrates the Power of Volunteerism
- DOMAINfest Global 2010 Offers Compelling Agenda and Expert Speakers
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
- Merck Serono to Expand Research and Development Presence in China
- Stem Cell Therapeutics Corp. Announces That Dr. Allen Davidoff Will Present at the 2009 Neural Restoration Workshop Series
- Nihon Kohden America Announces the Auction of Its Latest EEG Technology in Support of the AES Lennox and Lombroso Trust for Epilepsy Research and Training
- Contrary Opinion: CRM is a Hoax
- An Introduction to My Health 2.0 Blog
- Michael Jackson's Death from Cardiac Arrest
- Desiccated Thyroid as a Treatment Option
- RNL BIO Rescues a College Student from Autoimmune Hearing Loss
- About Disability Resource Exchange Social Network
- Blood Test May Predict Course of MS
- NMSDC Recognizes Top Regional Minority Suppliers
- National Institutes of Health Awards More Than $54 Million to Kaiser Permanente to Conduct Health Research
- Inclusion Has Come A Long Way..
- Chase and Facebook Announce 100 Small and Local Charities to Receive $25,000 Each from Chase Community Giving
- Se insta a expertos en privacidad internacionales a aplicar Privacy by Design en sus jurisdicciones
Subscribe to Disability Nexus Email News Alerts
Subscribe via RSS
Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.